Transaction · 0002014386-26-000008

Murray Jason Hulse

Murray Jason Hulse, CF, CEO, CHAIR, reported an open-market or private sale at PACS Group, Inc. involving 27590.000000 shares for an estimated $1220771.97. Reported holdings after the transaction were 54694866.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCF, CEO, CHAIR
PACSPACS Group, Inc.
Filing timeAug 24
Trade dateAug 21, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$44.25
Pre-filing
1mo ago +1.8%1w ago +0.4%1d ago -1.5%
Returns since
7d -0.7%30d -0.7%90d -0.7%180d -0.7%1y -0.7%

PACS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PACS since 2026-08-24Filed 11 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002014386-26-000008
Common Stock
Transaction date
Aug 21, 2026
Filed Aug 24, 2026, 09:56 PM · 3d delay
Shares
27.5k sh
$4.42k per share
Estimated value
-$122M
Computed from shares × price
Holdings after
54.6M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Co-Founder, CEO & Chairman

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.30 to $44.29 per share of common stock. The Reporting Person un…

  3. F3

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.31 to $45.165 per share of common stock. The Reporting Person u…

  4. F4

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.05 to $44.045 per share of common stock. The Reporting Person u…

  5. F5

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.05 to $44.52 per share of common stock. The Reporting Person un…

Original filing · 0002014386-26-000008
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PACS